Hamid Ghandehari, Ph.D.
Dr. Ghandehari is a Professor at the Departments of Pharmaceutics and Pharmaceutical Chemistry and Bioengineering, Director of Utah Center for Nanomedicine, Co-Founder and Co-Director of the Nano Institute of Utah and Director of the University of Utah Nanotechnology Training Program. His research focuses on the design of new polymers for gene therapy of head and neck cancer, targeted delivery of polymer therapeutics to solid tumors, oral delivery of chemotherapeutics, and assessing the biocompatibility of silica and dendritic nanoconstructs. Dr. Ghandehari is Editor in Chief of Advanced Drug Delivery Reviews, Fellow of the American Institute for Medical and Biological Engineering, the American Association of Pharmaceutical Scientists, and Controlled Release Society, and serves on boards of several drug delivery journals and organizations. He received his BS in Pharmacy and PhD in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah.